Summary
This business focuses on advancing next-generation therapies, particularly for endocrine disorders. They have developed a unique Encapsulated Cell Replacement Therapy (EnCRT) that enables cells to survive in the body and function as smart molecular factories, releasing therapeutics as needed. Their initial pipeline targets endocrine disorders, specifically addressing hypoglycemia in type 1 diabetes, with a goal of providing long-term therapeutic solutions through a single implant.
Based on content on encellin.com
No similar companies found
We offer API access to our data.
8 of 8 checks passed
Label
Value
Active Dates
20.8 years — Since Mar 2004
Web Hosting
Platform
E-Mail Provider
Google GSuite
NAICS Code
621511
SIC 4 Digit Code
8731
SIC 2 Digit Code
87
Industry
1. Biotechnology and Healthcare
2. Medical Laboratories
Vendor
Source
TXT Record
Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2004 |
|
|
|
|
|
|
|
|
|
|
|
|
2005 |
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
|
|
|
|
|
|
2008 |
|
|
|
|
|
|
|
|
|
|
|
|
2009 |
|
|
|
|
|
|
|
|
|
|
|
|
2010 |
|
|
|
|
|
|
|
|
|
|
|
|
2011 |
|
|
|
|
|
|
|
|
|
|
|
|
2012 |
|
|
|
|
|
|
|
|
|
|
|
|
2013 |
|
|
|
|
|
|
|
|
|
|
|
|
2014 |
|
|
|
|
|
|
|
|
|
|
|
|
2015 |
|
|
|
|
|
|
|
|
|
|
|
|
2016 |
|
|
|
|
|
|
|
|
|
|
|
|
2017 |
|
|
|
|
|
|
|
|
|
|
|
|
2018 |
|
|
|
|
|
|
|
|
|
|
|
|
2019 |
|
|
|
|
|
|
|
|
|
|
|
|
2020 |
|
|
|
|
|
|
|
|
|
|
|
|
2021 |
|
|
|
|
|
|
|
|
|
|
|
|
2022 |
|
|
|
|
|
|
|
|
|
|
|
|
2023 |
|
|
|
|
|
|
|
|
|
|
|
|
2024 |
|
|
|
|
|
|
|
|
|
|
|
|